• GPI Home
  • Solutions
    • GPI pulse™
    • GPI Consulting
    • GPI Horizon Methodology
    • Case Studies
  • About Us
    • Our Team
    • Careers
  • Contact Us
  • Discover
    • Blog
    • Events
    • Resources
  • GPI Direct
Month: June 2020
June 25, 2020 by Global Pricing Innovations (GPI)
GPI WEBINAR: Orphan price and access forecasting – a Must for return on investment in changing times

Click HERE to Register At GPI, working daily with price and reimbursement data, we have seen a range of PMA trends across high unmet need areas such as orphan/rare diseases. Increasing pharma focus on rare diseases resulted in payers having to adapt their…

June 18, 2020 by Global Pricing Innovations (GPI)
Dexamethasone: Will recent results on COVID-19 drive up the price?

By Musa Kureshy, Business Development Manager & Tom Brockbank, Senior Consultant On Tuesday 16th of June, new research was published by scientists from Oxford University which showed that the use of Dexamethasone, a low-dose steroid treatment, on patients suffering from COVID-19 reduced deaths…

June 10, 2020 by Global Pricing Innovations (GPI)
With Beneluxa Leading the Way, Will International HTA Collaboration Become the Norm?

By Ines Dieringer, Associate Consultant at Global Pricing Innovations Belgium, the Netherlands, and Ireland are aiming to undertake a joint Health Technology Assessment (HTA) through the Beneluxa agreement of Zolgensma, Novartis’ gene therapy medication to treat spinal muscular atrophy (SMA)1. Zolgensma is a…

Our partners
  • Privacy Policy
  • Terms of Use

| © Copyright 2018 Global Pricing Innovations. All Rights Reserved.

VAT registration: GB225169121